Tanvex BioPharma (Taiwan) Analysis
| 6541 Stock | TWD 70.30 2.20 3.23% |
Tanvex BioPharma is fairly valued with Real Value of 69.08 and Hype Value of 70.3. The main objective of Tanvex BioPharma stock analysis is to determine its intrinsic value, which is an estimate of what Tanvex BioPharma is worth, separate from its market price. There are two main types of Tanvex BioPharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Tanvex BioPharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Tanvex BioPharma's stock to identify patterns and trends that may indicate its future price movements.
The Tanvex BioPharma stock is traded in Taiwan on Taiwan Stock Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Tanvex BioPharma is usually not traded on National Day of the Republic of China. Tanvex Stock trading window is adjusted to Asia/Shanghai timezone.
Tanvex |
Tanvex Stock Analysis Notes
About 54.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 4.35. Tanvex BioPharma had not issued any dividends in recent years. The entity had 1000:333 split on the 28th of February 2023. Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. TANVEX BIOPHARMA is traded on Taiwan Stock Exchange in Taiwan. For more info on Tanvex BioPharma learn more at https://www.tanvex.com.Tanvex BioPharma Investment Alerts
| The company reported the revenue of 5.41 M. Net Loss for the year was (1.54 B) with profit before overhead, payroll, taxes, and interest of 3.55 M. | |
| Tanvex BioPharma has accumulated about 1.65 B in cash with (1.39 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.29. | |
| Roughly 54.0% of the company shares are owned by insiders or employees |
Tanvex Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 17.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tanvex BioPharma's market, we take the total number of its shares issued and multiply it by Tanvex BioPharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 26th of November, Tanvex BioPharma has the Semi Deviation of 1.53, risk adjusted performance of 0.0965, and Coefficient Of Variation of 859.3. Tanvex BioPharma technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Tanvex BioPharma downside deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Tanvex BioPharma is priced more or less accurately, providing market reflects its prevalent price of 70.3 per share.Tanvex BioPharma Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Tanvex BioPharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Tanvex BioPharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Tanvex BioPharma Outstanding Bonds
Tanvex BioPharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Tanvex BioPharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Tanvex bonds can be classified according to their maturity, which is the date when Tanvex BioPharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Tanvex BioPharma Predictive Daily Indicators
Tanvex BioPharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tanvex BioPharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Tanvex BioPharma Forecast Models
Tanvex BioPharma's time-series forecasting models are one of many Tanvex BioPharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tanvex BioPharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Tanvex Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Tanvex BioPharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tanvex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tanvex BioPharma. By using and applying Tanvex Stock analysis, traders can create a robust methodology for identifying Tanvex entry and exit points for their positions.
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. TANVEX BIOPHARMA is traded on Taiwan Stock Exchange in Taiwan.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Tanvex BioPharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Additional Tools for Tanvex Stock Analysis
When running Tanvex BioPharma's price analysis, check to measure Tanvex BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanvex BioPharma is operating at the current time. Most of Tanvex BioPharma's value examination focuses on studying past and present price action to predict the probability of Tanvex BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanvex BioPharma's price. Additionally, you may evaluate how the addition of Tanvex BioPharma to your portfolios can decrease your overall portfolio volatility.